Zomedica Corp. (AMEX:ZOM) Q3 2023 Earnings Call Transcript November 13, 2023 Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Zomedica’s Third Quarter 2023 Earnings Release and Business Update Call. I would like to remind everyone that this conference call is being recorded today, Monday, November 13th, 2023 at 4.30 […]
A large review has found no difference in overall survival with fixed-duration vs ongoing ICI treatment in progression-free non–small cell lung cancer.
The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.
SMALL-CAP - WINNERS
Oxford BioMedica PLC, up 1.2% at 412.5p, 12-month range. | May 15, 2023
Oxford BioMedica PLC on Tuesday reported a drop in annual revenue and swung to a loss, as a result of lower volumes and higher costs.
The Oxfordshire, England-based gene and cell therapy group posted. | April 25, 2023